553 related articles for article (PubMed ID: 26604731)
21. Exacerbations of chronic obstructive pulmonary disease.
Wedzicha JA; Donaldson GC
Respir Care; 2003 Dec; 48(12):1204-13; discussion 1213-5. PubMed ID: 14651761
[TBL] [Abstract][Full Text] [Related]
22. [ Erdosteine (Mucodox), oral administration].
J Pharm Belg; 2011 Jun; (2):55-6. PubMed ID: 21823444
[No Abstract] [Full Text] [Related]
23. A controlled multicenter pediatric study in the treatment of acute respiratory tract diseases with the aid of a new specific compound, erdosteine (IPSE, Italian Pediatric Study Erdosteine).
Titti G; Lizzio A; Termini C; Negri P; Fazzio S; Mancini C
Int J Clin Pharmacol Ther; 2000 Aug; 38(8):402-7. PubMed ID: 10984014
[TBL] [Abstract][Full Text] [Related]
24. L-Arginine Pathway in COPD Patients with Acute Exacerbation: A New Potential Biomarker.
Ruzsics I; Nagy L; Keki S; Sarosi V; Illes B; Illes Z; Horvath I; Bogar L; Molnar T
COPD; 2016; 13(2):139-45. PubMed ID: 26514682
[TBL] [Abstract][Full Text] [Related]
25. Prognostic factors for clinical failure of exacerbations in elderly outpatients with moderate-to-severe COPD.
Wilson R; Anzueto A; Miravitlles M; Arvis P; Haverstock D; Trajanovic M; Sethi S
Int J Chron Obstruct Pulmon Dis; 2015; 10():985-93. PubMed ID: 26082623
[TBL] [Abstract][Full Text] [Related]
26. [Correlation among the levels of C-reactive protein and interleukin-18, quality of life, and lung function in patients with chronic obstructive pulmonary disease].
Long H; Luo H; Chen P; Li Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Nov; 36(11):1090-6. PubMed ID: 22169727
[TBL] [Abstract][Full Text] [Related]
27. High sensitive C-reactive protein for prediction of adverse outcome in acute exacerbation of chronic obstructive pulmonary disease.
Tofan F; Rahimi-Rad MH; Rasmi Y; Rahimirad S
Pneumologia; 2012; 61(3):160-2. PubMed ID: 23175870
[TBL] [Abstract][Full Text] [Related]
28. Point-of-care procalcitonin test to reduce antibiotic exposure in patients hospitalized with acute exacerbation of COPD.
Corti C; Fally M; Fabricius-Bjerre A; Mortensen K; Jensen BN; Andreassen HF; Porsbjerg C; Knudsen JD; Jensen JU
Int J Chron Obstruct Pulmon Dis; 2016; 11():1381-9. PubMed ID: 27382274
[TBL] [Abstract][Full Text] [Related]
29. Compare the efficacy of inhaled budesonide and systemic methylprednisolone on systemic inflammation of AECOPD.
Sun X; He Z; Zhang J; Deng J; Bai J; Li M; Zhong X
Pulm Pharmacol Ther; 2015 Apr; 31():111-6. PubMed ID: 25281894
[TBL] [Abstract][Full Text] [Related]
30. Comparison of two systemic steroid regimens for the treatment of COPD exacerbations.
Ceviker Y; Sayiner A
Pulm Pharmacol Ther; 2014 Apr; 27(2):179-83. PubMed ID: 23518215
[TBL] [Abstract][Full Text] [Related]
31. Reduction of corticosteroid use in outpatient treatment of exacerbated COPD - Study protocol for a randomized, double-blind, non-inferiority study, (The RECUT-trial).
Urwyler P; Boesing M; Abig K; Cattaneo M; Dieterle T; Zeller A; Bachler H; Markun S; Senn O; Merlo C; Essig S; Ullmer E; Rutishauser J; Schuurmans MM; Leuppi JD
Trials; 2019 Dec; 20(1):727. PubMed ID: 31842993
[TBL] [Abstract][Full Text] [Related]
32. C-reactive protein levels in patients with chronic obstructive pulmonary disease: role of infection.
Bircan A; Gokirmak M; Kilic O; Ozturk O; Akkaya A
Med Princ Pract; 2008; 17(3):202-8. PubMed ID: 18408388
[TBL] [Abstract][Full Text] [Related]
33. Recovery Following Acute Exacerbations of Chronic Obstructive Pulmonary Disease - A Review.
Wageck B; Cox NS; Holland AE
COPD; 2019 Feb; 16(1):93-103. PubMed ID: 31044644
[TBL] [Abstract][Full Text] [Related]
34. Correlation between decrease of CRP and resolution of airway inflammatory response, improvement of health status, and clinical outcomes during severe acute exacerbation of chronic obstructive pulmonary disease.
Liang Y; Chang C; Zhu H; Shen N; He B; Yao W
Intern Emerg Med; 2015 Sep; 10(6):685-91. PubMed ID: 25822151
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of a respiratory rehabilitation exercise training package in hospitalized elderly patients with acute exacerbation of COPD: a randomized control trial.
Liao LY; Chen KM; Chung WS; Chien JY
Int J Chron Obstruct Pulmon Dis; 2015; 10():1703-9. PubMed ID: 26345529
[TBL] [Abstract][Full Text] [Related]
36. The effect of positive expiratory pressure (PEP) therapy on symptoms, quality of life and incidence of re-exacerbation in patients with acute exacerbations of chronic obstructive pulmonary disease: a multicentre, randomised controlled trial.
Osadnik CR; McDonald CF; Miller BR; Hill CJ; Tarrant B; Steward R; Chao C; Stodden N; Oliveira CC; Gagliardi N; Holland AE
Thorax; 2014 Feb; 69(2):137-43. PubMed ID: 24005444
[TBL] [Abstract][Full Text] [Related]
37. Serum Surfactant Protein Levels in Patients Admitted to the Hospital with Acute COPD Exacerbation.
Papaioannou AI; Konstantelou E; Papaporfyriou A; Bartziokas K; Spathis A; Bakakos P; Loukides S; Koulouris N; Papiris S; Kostikas K
Lung; 2018 Apr; 196(2):201-205. PubMed ID: 29445934
[TBL] [Abstract][Full Text] [Related]
38. Real-life data on antibiotic prescription and sputum culture diagnostics in acute exacerbations of COPD in primary care.
Bathoorn E; Groenhof F; Hendrix R; van der Molen T; Sinha B; Kerstjens HA; Friedrich AW; Kocks JW
Int J Chron Obstruct Pulmon Dis; 2017; 12():285-290. PubMed ID: 28144133
[TBL] [Abstract][Full Text] [Related]
39. Corticosteroids in the treatment of acute exacerbations of chronic obstructive pulmonary disease.
Woods JA; Wheeler JS; Finch CK; Pinner NA
Int J Chron Obstruct Pulmon Dis; 2014; 9():421-30. PubMed ID: 24833897
[TBL] [Abstract][Full Text] [Related]
40. Copeptin, C-reactive protein, and procalcitonin as prognostic biomarkers in acute exacerbation of COPD.
Stolz D; Christ-Crain M; Morgenthaler NG; Leuppi J; Miedinger D; Bingisser R; Müller C; Struck J; Müller B; Tamm M
Chest; 2007 Apr; 131(4):1058-67. PubMed ID: 17426210
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
